Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 555 Lymphoma 447 Precursor Cell Lymphoblastic Leukemia-Lymphoma 413 Lymphoma, Large B-Cell, Diffuse 348 Leukemia 346 Multiple Myeloma 336 Lymphoma, Non-Hodgkin 317 Leukemia, Myeloid, Acute 289 Leukemia, Lymphocytic, Chronic, B-Cell 286 Lymphoma, Follicular 241 Burkitt Lymphoma 217 Myelodysplastic Syndromes 211 Lymphoma, Mantle-Cell 202 Hodgkin Disease 193 Recurrence 153 Lymphoma, B-Cell, Marginal Zone 142 Melanoma 135 Lymphoma, Large-Cell, Immunoblastic 116 Neoplasms 109 Lymphoma, B-Cell 103 Neuroblastoma 101 Neoplasms, Plasma Cell 99 Triple Negative Breast Neoplasms 94 Ovarian Neoplasms 94 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 91 Myeloproliferative Disorders 87 Hematologic Neoplasms 87 Leukemia, Myeloid, Chronic-Phase 83 Leukemia, Myeloid, Accelerated Phase 80 Leukemia, Myelomonocytic, Chronic 78

Interventions

Fulvestrant 6 Letrozole 4 Capecitabine 4 exemestane 3 dalpiciclib 3 Trastuzumab 3 Docetaxel 3 Anastrozole 3 ribociclib 2 palbociclib 2 fluzoparib 2 apatinib 2 Irinotecan 2 Gemcitabine 2 tusamitamab ravtansine 1 trastuzumab deruxtecan 1 sacituzumab govitecan 1 pyrotinib 1 pegfilgrastim 1 patritumab deruxtecan 1 olaparib 1 nirogacestat 1 margetuximab 1 irinotecan sucrosofate 1 abemaciclib 1 Zoledronic Acid 1 Vinorelbine 1 Tamoxifen 1 Rogaratinib 1 Patient Reported Outcome Measures 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Cancer Metastatic × Cyclophosphamide × Clear all

NCT04350021 2024-01-17

METRO

Vastra Gotaland Region

Breast Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡